Elite Pharmaceuticals, Inc. Announces Renewed Manufacturing and Supply Agreement With ThePharmaNetwork, LLC
Published: Sep 28, 2012
NORTHVALE, N.J., Sept. 28, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP) announced that it has renewed its commercial Manufacturing and Supply Agreement with ThePharmaNetwork, LLC, and its wholly owned subsidiary, Ascend Laboratories, LLC (together "TPN"). Under the terms of the amended agreement, Elite will continue to perform manufacturing and packaging for TPN's Methadone Hydrochloride, 10 mg tablets through December 31, 2014.